# Product Roadmap - Chest X-Ray Pneumonia Detector

## Vision
To create a production-ready, HIPAA-compliant AI system for pneumonia detection from chest X-ray images that can be safely deployed in clinical environments.

## Current Status (v0.2.0)
- ✅ Core CNN model architecture implemented
- ✅ Transfer learning with multiple pre-trained models
- ✅ Grad-CAM interpretability features
- ✅ MLflow experiment tracking
- ✅ Basic CLI tools for training and inference
- ✅ Comprehensive test suite with security scanning

## Short Term Goals (Q3-Q4 2025)

### v0.3.0 - Production Infrastructure
**Target: August 2025**
- [ ] Docker containerization with multi-stage builds
- [ ] FastAPI REST API for model serving
- [ ] Health monitoring and metrics collection
- [ ] HIPAA-compliant logging and audit trails
- [ ] Comprehensive CI/CD pipeline with GitHub Actions
- [ ] Security scanning and SBOM generation

### v0.4.0 - Enhanced ML Capabilities
**Target: September 2025**
- [ ] Ensemble model support for improved accuracy
- [ ] Uncertainty quantification for predictions
- [ ] Model drift detection and monitoring
- [ ] Advanced data augmentation techniques
- [ ] Cross-validation framework improvements
- [ ] Performance benchmarking suite

### v0.5.0 - Clinical Integration Preparation
**Target: October 2025**
- [ ] DICOM format support and processing
- [ ] Integration with PACS systems
- [ ] Clinical decision support features
- [ ] Batch processing capabilities for high throughput
- [ ] Advanced model interpretability dashboard
- [ ] Compliance documentation and validation

## Medium Term Goals (Q1-Q2 2026)

### v1.0.0 - Clinical Deployment Ready
**Target: March 2026**
- [ ] FDA software as medical device compliance preparation
- [ ] Clinical validation with real-world datasets
- [ ] Multi-site deployment capabilities
- [ ] Advanced security controls and access management
- [ ] Comprehensive clinical documentation
- [ ] User training materials and certification

### v1.1.0 - Advanced Features
**Target: June 2026**
- [ ] Multi-modal AI (chest X-rays + clinical data)
- [ ] Federated learning capabilities
- [ ] Real-time inference optimization
- [ ] Mobile/edge deployment options
- [ ] Advanced analytics and reporting dashboard
- [ ] Integration with EMR/EHR systems

## Long Term Vision (2027+)

### v2.0.0 - Next Generation AI
- [ ] Vision Transformer architectures
- [ ] Multi-disease detection capabilities
- [ ] 3D imaging support (CT scans)
- [ ] Longitudinal patient analysis
- [ ] AI-driven clinical workflows
- [ ] Global deployment and localization

### v3.0.0 - Ecosystem Platform
- [ ] Plugin architecture for custom models
- [ ] Research collaboration platform
- [ ] Data marketplace for anonymized datasets
- [ ] AI model marketplace
- [ ] Advanced clinical decision support
- [ ] Population health analytics

## Key Milestones

| Milestone | Target Date | Description |
|-----------|-------------|-------------|
| Production Infrastructure | Aug 2025 | Complete containerization and CI/CD |
| Clinical Validation | Mar 2026 | Successful validation in clinical setting |
| FDA Submission | Jun 2026 | Submit for FDA 510(k) clearance |
| Commercial Launch | Q4 2026 | First commercial deployment |

## Technology Evolution

### Infrastructure Roadmap
- **Current**: Single-node deployment
- **Q4 2025**: Kubernetes orchestration
- **Q2 2026**: Multi-cloud deployment
- **2027+**: Edge computing and mobile deployment

### ML Model Roadmap
- **Current**: CNN with transfer learning
- **Q4 2025**: Ensemble methods and uncertainty quantification
- **Q2 2026**: Transformer architectures
- **2027+**: Multi-modal and generative AI

### Integration Roadmap
- **Current**: CLI and batch processing
- **Q4 2025**: REST API and web interface
- **Q2 2026**: PACS and EMR integration
- **2027+**: Real-time clinical workflows

## Success Metrics

### Technical Metrics
- **Model Performance**: >95% sensitivity, >90% specificity
- **System Performance**: <2s inference latency, 99.9% uptime
- **Security**: Zero security incidents, 100% compliance audits
- **Quality**: >95% test coverage, <1% defect rate

### Business Metrics
- **Clinical Adoption**: 10+ healthcare facilities by Q4 2026
- **Processing Volume**: 10,000+ X-rays per day
- **Clinical Impact**: 20% reduction in diagnostic time
- **Cost Effectiveness**: 30% reduction in unnecessary procedures

## Risk Management

### Technical Risks
- **Model Performance**: Continuous validation and monitoring
- **Security Vulnerabilities**: Regular security audits and updates
- **Scalability Issues**: Load testing and performance optimization
- **Data Quality**: Comprehensive data validation pipelines

### Regulatory Risks
- **FDA Approval**: Early engagement with regulatory consultants
- **HIPAA Compliance**: Regular compliance audits and updates
- **International Regulations**: Localization for global markets
- **Clinical Standards**: Alignment with medical imaging standards

### Market Risks
- **Competition**: Focus on clinical validation and ease of use
- **Technology Shifts**: Continuous research and development
- **Adoption Barriers**: Comprehensive training and support
- **Economic Factors**: Flexible pricing and deployment models

## Community and Open Source

### Current Contributions
- Open source core ML components
- Community-driven dataset curation
- Research collaboration partnerships
- Educational resources and tutorials

### Future Plans
- **Research Partnerships**: Collaboration with academic institutions
- **Industry Standards**: Contribute to medical AI standards
- **Open Datasets**: Curated, anonymized datasets for research
- **Developer Ecosystem**: Tools and SDKs for third-party integration

## Dependencies and Prerequisites

### Technical Dependencies
- TensorFlow ecosystem maturity
- Healthcare cloud platform capabilities
- Medical imaging standards evolution
- Security and compliance frameworks

### Business Dependencies
- Clinical validation partnerships
- Regulatory approval processes
- Healthcare system integration capabilities
- Market adoption and funding

This roadmap is reviewed quarterly and updated based on clinical feedback, technology evolution, and market conditions.